Picture: Lytix Biopharma

Lytix Biopharma: CBO-Position new filled

Oslo-based Lytix Biopharma has a new Chief Business Officer. Stephen Worsley has started at the Norwegian immune-oncology company at the beginning of September.

Worsley has more than 25 years of experience in business development in senior positions. Most recently, he served as Vice President Strategic Business Development at Redwood Bioscience/Catalent Pharma Services. His other positions include CBO at Sutro Biopharma, Sr. Vice President Business Development at IndiMolecular and VP of Business Development at Peregrine Pharmaceutical (dba Avid Pharma Services).